Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$868M |
| 2 |
Amazon
AMZN
|
+$726M |
| 3 |
UnitedHealth
UNH
|
+$571M |
| 4 |
Rivian
RIVN
|
+$559M |
| 5 |
TJX Companies
TJX
|
+$441M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$1.09B |
| 2 |
NVIDIA
NVDA
|
+$762M |
| 3 |
L3Harris
LHX
|
+$742M |
| 4 |
Zurn Elkay Water Solutions
ZWS
|
+$497M |
| 5 |
Texas Instruments
TXN
|
+$477M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.51% |
| 2 | Healthcare | 18.41% |
| 3 | Consumer Discretionary | 11.39% |
| 4 | Financials | 9.7% |
| 5 | Industrials | 8.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
776
SLB Ltd
SLB
$72.7B
| $20.7M | 0.01% |
691,028
-899
| -0.1% | -$28.3K |
|
777
AT&T
T
$164B
| $20.7M | 0.01% |
1,112,806
-125,698
| -10% | -$2.35M |
|
|
CYT
778
DELISTED
Cyteir Therapeutics, Inc. Common Stock
CYT
| $20.6M | 0.01% |
1,872,421
-5,803
| -0.3% | -$88.4K |
|
|
HSKA
779
DELISTED
Heska Corp
HSKA
| $20.5M | 0.01% |
112,545
-30,660
| -21% | -$6.1M |
|
780
Anika Therapeutics
ANIK
$215M
| $20.5M | 0.01% |
571,895
+108,110
| +23% | +$4.33M |
|
781
EyePoint Inc
EYPT
$999M
| $20.5M | 0.01% |
1,671,183
+958,799
| +135% | +$12.9M |
|
782
Franklin FTSE Japan ETF
FLJP
$3.86B
| $20.4M | 0.01% |
694,833
+16,097
| +2% | +$482K |
|
783
Darden Restaurants
DRI
$24.3B
| $20.4M | 0.01% |
135,104
-495,597
| -79% | -$73.3M |
|
784
Perimeter Solutions
PRM
$5.66B
| $20.3M | 0.01% |
+1,461,014
| New | +$18.5M |
|
785
PNC Financial Services
PNC
$99.1B
| $20.2M | 0.01% |
100,662
-168,278
| -63% | -$34.2M |
|
|
NLSN
786
DELISTED
Nielsen Holdings plc
NLSN
| $20.2M | 0.01% |
983,486
+929,387
| +1,718% | +$18.9M |
|
787
GitLab
GTLB
$5.75B
| $20.1M | 0.01% |
+230,933
| New | +$23.6M |
|
788
CarParts.com
PRTS
$42.6M
| $20.1M | 0.01% |
179,274
+70,104
| +64% | +$9.65M |
|
789
Fortune Brands Innovations
FBIN
$5.86B
| $19.9M | 0.01% |
218,349
+173,319
| +385% | +$15M |
|
790
Northern Trust
NTRS
$21.8B
| $19.9M | 0.01% |
166,038
-87,858
| -35% | -$10.5M |
|
|
WBA
791
DELISTED
Walgreens Boots Alliance
WBA
| $19.8M | 0.01% |
380,263
-376,656
| -50% | -$18.2M |
|
792
Mirion Technologies
MIR
$3.56B
| $19.8M | 0.01% |
1,892,034
+822,472
| +77% | +$8.83M |
|
793
ALX Oncology
ALXO
$262M
| $19.8M | 0.01% |
918,908
-106,491
| -10% | -$4.59M |
|
794
C.H. Robinson
CHRW
$20.5B
| $19.4M | 0.01% |
180,104
-101,138
| -36% | -$9.82M |
|
|
ONT
795
Onterris Inc
ONT
$731M
| $19.3M | 0.01% |
273,811
-93,355
| -25% | -$6.47M |
|
|
UMH
796
UMH Properties
UMH
$1.34B
| $19.3M | 0.01% |
+705,531
| New | +$17M |
|
|
ABMD
797
DELISTED
Abiomed Inc
ABMD
| $19.1M | 0.01% |
53,095
-28,232
| -35% | -$9.54M |
|
798
Design Therapeutics
DSGN
$751M
| $19.1M | 0.01% |
936,767
+108
| +0% | +$1.85K |
|
799
ScottsMiracle-Gro
SMG
$4.09B
| $19M | 0.01% |
117,769
-13,963
| -11% | -$2.16M |
|
800
3M
MMM
$91.8B
| $18.9M | 0.01% |
127,195
-138,571
| -52% | -$20.6M |
|
Similar funds
Janus Henderson Group's Q4 2021 Portfolio in Review
As of Q4 2021, Janus Henderson Group held 2,654 positions worth $240B, up 4.9% from $229B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Janus Henderson Group's Q4 2021 filing shows 464 new, 1,324 increased, 690 reduced and 110 closed positions. Its largest new stake was Rivian: 4,856,003 shares worth $504M. The largest sale was Meta Platforms (Facebook), an estimated $1.09B.
By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 31% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Janus Henderson Group's largest Q4 2021 buy was Rivian: 4,856,003 shares worth $504M.
- Janus Henderson Group added most to Apple in Q4 2021, an estimated $868M increase.
- Janus Henderson Group's biggest Q4 2021 reduction was Meta Platforms (Facebook), cutting an estimated $1.09B.
- Janus Henderson Group fully exited Acceleron Pharma in Q4 2021, selling an estimated $274M.
- Janus Henderson Group's ten largest holdings make up 25% of its $240B portfolio in Q4 2021.
- Janus Henderson Group opened 464 new positions and closed 110 in Q4 2021.
- Janus Henderson Group's portfolio value rose 4.9% quarter-over-quarter to $240B.
Based on Janus Henderson Group's 13F filing for Q4 2021, filed 14 Feb 2022.